Prospective Data Reveal Most Young Survivors of Breast Cancer Could Successfully Give Birth Read More » May 23, 2024
FDA Grants Fast Track Designation to VCN-01 in Metastatic Pancreatic Cancer Read More » May 23, 2024
Inavolisib Receives FDA Breakthrough Therapy Designation for PIK3CA-Mutated, HR+/HER2– Breast Cancer Read More » May 21, 2024
IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate: Data Submitted to FDA Requesting Marketing Authorization to Treat Early-Stage Breast Cancer Read More » April 15, 2024
